| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.36 | 0.008 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.45 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |